Citi Starts PRA Health Sciences (PRAH) at Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- S&P 500 and Nasdaq set to open higher as CPI, bank earnings take focus; IBM tumbles
- IBM plunges 19% as memory capex squeeze derails Q2 earnings
- SK Hynix’s record plunge drags down global chip stocks
- Software stocks tumble: High memory prices cannibalize enterprise tech capex
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- IBM misses Q2 targets as mainframe and software sales disappoint
- Goldman Sachs Upgrades NIO (NIO) to Buy
- BofA Securities on AppLovin: 'Current valuation appears reasonable'
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- YPF Energía Eléctrica S.A. files for proposed NYSE IPO
UPDATE: Credit Suisse Starts PRA Health Sciences (PRAH) at Outperform
December 8, 2014 9:23 AM EST(Updated - December 8, 2014 10:30 AM EST)
Credit Suisse initiated coverage on PRA Health Sciences (NASDAQ: PRAH) with an Outperform rating and a price target of $27.00.
"PRAH is a global clinical contract research organization (CRO) that provides outsourced services to support all stages of the clinical... More
UBS Starts PRA Health Sciences (PRAH) at Buy
December 8, 2014 7:55 AM ESTUBS initiated coverage on PRA Health Sciences (NASDAQ: PRAH) with a Buy rating and a price target of $28.00.
For an analyst ratings summary and ratings history on PRA Health Sciences click here. For more ratings news on PRA Health Sciences click here.
Shares of PRA Health Sciences closed at $22.06 yesterday.
... MoreBaird Starts PRA Health Sciences (PRAH) at Outperform
December 8, 2014 7:54 AM ESTBaird initiated coverage on PRA Health Sciences (NASDAQ: PRAH) with an Outperform rating and a price target of $28.00.
For an analyst ratings summary and ratings history on PRA Health Sciences click here. For more ratings news on PRA Health Sciences click here.
Shares of PRA Health Sciences closed at $22.06 yesterday.
... MoreWells Fargo Starts PRA Health Sciences (PRAH) at Outperform
December 8, 2014 7:54 AM ESTWells Fargo initiated coverage on PRA Health Sciences (NASDAQ: PRAH) with an Outperform rating and a price target of $25-$26.
For an analyst ratings summary and ratings history on PRA Health Sciences... More
Jefferies Starts PRA Health Sciences (PRAH) at Buy
December 8, 2014 7:42 AM ESTJefferies initiates coverage on PRA Health Sciences (NASDAQ: PRAH) with a Buy rating and a price target of $27.00.
Analyst David Windley comments, "PRA's project-based and functional service solutions combined with the additive RPS client base offer significant cross-selling opportunities and the potential for... More
